|
Market Closed -
London S.E.
23:35:12 04/09/2026 HKT
|
5-day change | 1st Jan Change | ||
| 146.50 GBX | 0.00% |
|
+2.09% | +14.45% |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
Geographical Revenue Distribution History
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Life Sciences Tools and Services | ||||||||||
Medical Labs & Research | 13.94M | 19.5M | 23.7M | 32.16M | 38.44M | |||||
Total Assets | 45.01M | 48.26M | 46.34M | 48.62M | 50.01M | |||||
Interest Expense | -88K | -120K | -66K | -54K | -58K | |||||
Income Tax Expense | -99K | -160K | -692K | -205K | 205K | |||||
CAPEX | -5.6M | -4.87M | -125K | -100K | -71K | |||||
EBT | 462K | 564K | -2.44M | -1.91M | 302K | |||||
Gross Profit | 10.73M | 16.74M | 19.71M | 28.27M | 31.48M | |||||
D&A | 1.02M | 1.66M | 3.27M | 3.16M | 4.33M | |||||
Operating Income | 550K | 575K | -3.02M | -2.46M | 43K | |||||
Net Income | 561K | 724K | -1.75M | -1.7M | 97K |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
North America | 8.46M | 14.45M | 20.83M | 29.54M | 35.85M | |||||
| - | - | - | - | 33K | ||||||
Europe | 3.62M | 2.7M | 2.47M | 1.89M | 1.79M | |||||
UK | 555K | 561K | 352K | 547K | 766K | |||||
Asia and Rest of World | 1.31M | 1.79M | 45K | 181K | 33K | |||||
Asia | - | - | - | - | - | |||||
| - | - | - | - | 35.85M | ||||||
USA | - | - | - | - | - | |||||
| - | - | - | - | 1.79M | ||||||
Europe and USA | - | - | - | - | - | |||||
| - | - | - | - | 766K |
- Stock Market
- Stocks
- DXRX Stock
- Financials Diaceutics PLC
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
